Cardiac contractility modulation (CCM) and carotid sinus nerve stimulation (Barostim) adverse events.
Total Reports
468
Devices Tracked
26
Reports (30d)
18
Active Signals
4
| Device | Total Reports | Last 30d |
|---|---|---|
Barostim NEO2DSR | 196 | 9 |
BAROSTIM NEODSR | 94 | 5 |
OPTIMIZERQFV | 88 | 4 |
BAROSTIM NEODSR | 47 | 0 |
OPTIMIZER™QFV | 16 | 0 |
BarostimDSR | 5 | 0 |
Neo LegacyDSR | 5 | 0 |
BAROSTIM NEODSR | 4 | 0 |
IMPLANTABLE PULSE GENERATORQFV | 3 | 0 |
OPTIMIZERQFV | 2 | 0 |
OPTIMIZER™QFV | 2 | 0 |
OMNI™ IIQFV | 1 | 0 |
BAROSTIM NEODSR | 1 | 0 |
OPTIMIZER SMART MINIQFV | 1 | 0 |
CCM DEVICEQFV | 1 | 0 |
CVRX IMPLANTABLE PULSE GENERATORDSR | 1 | 0 |
CHARGER DEVICEQFV | 1 | 0 |
GuardioQFV | 0 | 0 |
BAROSTIM ProgrammerDSR | 0 | 0 |
BAROSTIM Lead Repair KitDSR | 0 | 0 |
NADSR | 0 | 0 |
VestaQFV | 0 | 0 |
INFINITY 7 IMPLANTABLE PULSE GENERATORQFV | 0 | 0 |
VestaQFV | 0 | 0 |
IntelioQFV | 0 | 0 |
1–25 of 26 devices
Claripulse monitors these devices weekly and detects anomalies using 6 statistical methods — spike, trend, changepoint, peer-outlier, and more. 4 active signals detected right now.
Get Early Access